Aerosolized Ceftazidime Prophylaxis against Ventilator-Associated Pneumonia in High-Risk Trauma Patients: Results of A Double-Blind Randomized Study

Abstract

The use of aerosolized ceftazidime did not reduce the rate of VAP in high-risk patients admitted after traumatic injury, but neither did it increase the incidence of other infectious complications. Routine use of prophylactic aerosolized ceftazidime to prevent VAP in trauma patients cannot be recommended.